TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
TherapeuticsMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.86−0.04 (-2.11%)
Close on Oct 19, 2026
- Market cap
- $21.66M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
31.7%
4M of 12M shares
Institutional holders
45
5 new, 7 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $14.03K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Baselake Management, LLC | 790,703 | 6.80% | 13G (passive) amendment | Jun 30, 2026 |
| Clearline Capital LP | 635,222 | 5.50% | 13G (passive) | Dec 31, 2024 |
| Baselake Partners, LP | 607,181 | 5.20% | 13G (passive) | Mar 30, 2026 |
| Rubric Capital Management LP | 2,946,908 | 25.73% | 13D (active) amendment | Nov 15, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TXMD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 1,192,191 | 10.30% | $2.63M | – | 0.02% |
| Clearline Capital LP | 635,222 | 5.49% | $1.40M | – | 0.08% |
| Vanguard Capital Management LLC | 353,697 | 3.06% | $781.67K | – | 0.00% |
| Tejara Capital Ltd | 344,482 | 2.98% | $761.31K | −1,370 | 0.31% |
| ADAR1 Capital Management, LLC | 342,447 | 2.96% | $756.81K | +133,237 | 0.03% |
| Renaissance Technologies LLC | 146,599 | 1.27% | $323.98K | +399 | 0.00% |
| Morgan Stanley | 129,217 | 1.12% | $285.57K | – | 0.00% |
| BlackRock, Inc. | 115,145 | 0.99% | $254.47K | – | 0.00% |
| Geode Capital Management, LLC | 105,849 | 0.91% | $233.99K | −3,968 | 0.00% |
| Citadel Advisors LLC | 86,095 | 0.74% | $190.27K | +17,781 | 0.00% |
| Vanguard Fiduciary Trust Co | 63,831 | 0.55% | $141.07K | – | 0.00% |
| State Street Corp | 30,100 | 0.26% | $66.52K | – | 0.00% |
| XTX Topco Ltd | 21,246 | 0.18% | $46.95K | −6,241 | 0.00% |
| Dimensional Fund Advisors LP | 19,719 | 0.17% | $43.58K | +9,013 | 0.00% |
| Northern Trust Corp | 18,556 | 0.16% | $41.01K | +2,463 | 0.00% |
| Bridgeway Capital Management, LLC | 17,000 | 0.15% | $37.57K | – | 0.00% |
| Osaic Holdings, Inc. | 15,198 | 0.13% | $33.59K | +15,045 | 0.00% |
| Hrt Financial LP | 14,727 | 0.13% | $32 | New | 0.00% |
| Vanguard Global Advisers, LLC | 4,937 | 0.04% | $10.91K | – | 0.00% |
| UBS Group AG | 4,660 | 0.04% | $10.30K | +4,329 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 45 | 4M | 31.7% | 5 / 11 | 4 / 7 | 0M | 0M |
| Q1 2026 | 49 | 4M | 34.0% | 10 / 7 | 9 / 3 | 1M | 0M |
| Q4 2025 | 44 | 3M | 29.2% | 4 / 7 | 8 / 6 | 0M | 0M |
| Q3 2025 | 46 | 3M | 28.5% | 7 / 4 | 11 / 3 | 0M | 0M |
| Q2 2025 | 42 | 3M | 28.1% | 2 / 9 | 8 / 2 | 0M | 0M |
| Q1 2025 | 42 | 3M | 28.9% | 5 / 7 | 7 / 4 | 0M | 0M |
| Q4 2024 | 41 | 4M | 30.5% | 8 / 3 | 6 / 4 | 0M | 0M |
| Q3 2024 | 37 | 3M | 29.2% | 5 / 3 | 5 / 5 | 0M | 0M |
| Q2 2024 | 38 | 3M | 29.5% | 3 / 6 | 11 / 8 | 0M | 0M |
| Q1 2024 | 43 | 4M | 31.5% | 8 / 7 | 7 / 4 | 0M | 0M |
| Q4 2023 | 39 | 3M | 29.2% | 6 / 6 | 10 / 3 | 0M | 0M |
| Q3 2023 | 36 | 3M | 25.8% | 4 / 7 | 6 / 10 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of TXMD | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 244,317 | 2.11% | $539.94K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 109,380 | 0.95% | $241.73K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 65,183 | 0.56% | $139.49K | 0.00% | May 31, 2026 |
| Ultra-Small Company Market Fund | 17,000 | 0.15% | $37.57K | 0.03% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 15,320 | 0.13% | $32.78K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 14,835 | 0.13% | $31.75K | 0.00% | May 31, 2026 |
| Dimensional U.S. Core Equity 2 ETF | 4,826 | 0.04% | $9.80K | 0.00% | Jul 31, 2026 |
| Dimensional US Sustainability Core 1 ETF | 3,612 | 0.03% | $7.33K | 0.00% | Jul 31, 2026 |
| The Gabelli ABC Fund | 3,600 | 0.03% | $7.96K | 0.00% | Jun 30, 2026 |
| Dimensional US Core Equity 1 ETF | 3,076 | 0.03% | $6.24K | 0.00% | Jul 31, 2026 |
| Enterprise Mergers and Acquisitions Fund | 1,000 | 0.01% | $2.21K | 0.00% | Jun 30, 2026 |
| Diversified Equity Alpha Master Portfolio | 745 | 0.01% | $1.65K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Marlan D. Walker | Chief Executive Officer | 73,639 | 0.64% | Nov 5, 2025 |
| Tommy G. Thompson | Director | 37,512 | 0.32% | Dec 29, 2025 |
| Cooper C. Collins | Director | 60,516 | 0.52% | Nov 5, 2025 |
| Gail K. Naughton | Director | 8,500 | 0.07% | Nov 5, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Tommy G. Thompson Director | Dec 23, 2025 | Buy | +8,400 | $1.67 | $14.03K | 23,179 |
| Tommy G. Thompson Director | Apr 14, 2025 | Buy | +325 | $1.00 | $325 | 14,779 |
| Marlan D. Walker Chief Executive Officer | Apr 14, 2025 | Buy | +490 | $1.00 | $490 | 73,639 |
| Marlan D. Walker Chief Executive Officer | Apr 10, 2025 | Buy | +1,167 | $0.86 | $1.00K | 73,149 |
| Marlan D. Walker Chief Executive Officer | Apr 9, 2025 | Buy | +1,136 | $0.87 | $988 | 71,982 |
| Tommy G. Thompson Director | Feb 18, 2025 | Option exercise | +8,500 | – | – | 14,454 |
| Gail K. Naughton Director | Feb 18, 2025 | Option exercise | +8,500 | – | – | 8,500 |
| Cooper C. Collins Director | Feb 18, 2025 | Option exercise | +8,500 | – | – | 60,516 |
| Marlan D. Walker Chief Executive Officer | Feb 18, 2025 | Option exercise | +3,467 | – | – | 66,032 |
| Marlan D. Walker Chief Executive Officer | Feb 18, 2025 | Option exercise | +2,311 | – | – | 68,343 |
| Marlan D. Walker Chief Executive Officer | Feb 18, 2025 | Option exercise | +1,733 | – | – | 70,846 |
| Marlan D. Walker Chief Executive Officer | Feb 18, 2025 | Option exercise | +770 | – | – | 69,113 |
| Cooper C. Collins Director | Aug 22, 2024 | Buy | +4,094 | $1.73 | $7.08K | 52,016 |
| Cooper C. Collins Director | Aug 21, 2024 | Buy | +1,200 | $1.70 | $2.04K | 47,922 |
| Marlan D. Walker Chief Executive Officer | Dec 7, 2023 | Sale | −4,550 | $2.24 | $10.19K | 62,565 |
| Marlan D. Walker Chief Executive Officer | Dec 6, 2023 | Sale | −14,500 | $2.31 | $33.50K | 67,115 |
| Marlan D. Walker Chief Executive Officer | Dec 5, 2023 | Option exercise | +70,000 | – | – | 81,615 |
| David Efraim Rosen 10% owner | Nov 15, 2023 | Award | +877,192 | $2.28 | $2.00M | 2,946,908 |
| Joseph Ziegler Principal Financial Officer | Aug 17, 2023 | Award | +7,500 | – | – | 7,500 |
| David Efraim Rosen Director, 10% owner | Jun 28, 2023 | Award | +312,525 | $3.68 | $1.15M | 2,069,716 |
| Marlan D. Walker Chief Executive Officer | Apr 26, 2023 | Sale | −692 | $3.64 | $2.52K | 11,615 |
| Marlan D. Walker Chief Executive Officer | Apr 26, 2023 | Option exercise | +1,010 | – | – | 14,041 |
| Marlan D. Walker Chief Executive Officer | Apr 26, 2023 | Option exercise | +1,734 | – | – | 12,307 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Apr 12, 2023 | Option exercise | +50,000 | – | – | 61,853 |
| Marlan D. Walker Chief Executive Officer | Apr 12, 2023 | Option exercise | +3,030 | – | – | 8,999 |
| Marlan D. Walker Chief Executive Officer | Apr 12, 2023 | Option exercise | +1,010 | – | – | 10,009 |
| Marlan D. Walker Chief Executive Officer | Apr 12, 2023 | Option exercise | +1,734 | – | – | 11,743 |
| Marlan D. Walker Chief Executive Officer | Apr 12, 2023 | Option exercise | +1,734 | – | – | 13,477 |
| Marlan D. Walker Chief Executive Officer | Apr 12, 2023 | Sale | −1,170 | $3.65 | $4.27K | 12,307 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Jan 27, 2023 | Sale | −49 | $5.09 | $249 | 11,853 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Jan 26, 2023 | Option exercise | +1,140 | – | – | 13,550 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Jan 26, 2023 | Sale | −1,648 | $5.08 | $8.37K | 11,902 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Jan 26, 2023 | Option exercise | +2,400 | – | – | 10,010 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Jan 26, 2023 | Option exercise | +2,400 | – | – | 12,410 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Jan 24, 2023 | Sale | −7 | $5.31 | $37 | 7,610 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Jan 23, 2023 | Option exercise | +519 | – | – | 6,519 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Jan 23, 2023 | Option exercise | +380 | – | – | 4,934 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Jan 23, 2023 | Option exercise | +1,066 | – | – | 6,000 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Jan 23, 2023 | Sale | −1,302 | $5.34 | $6.95K | 7,617 |
| Michael C. Donegan Prin. Fin. and Acctg. Officer | Jan 23, 2023 | Option exercise | +2,400 | – | – | 8,919 |
| Capital Management LP Rubric Director, 10% owner | Dec 30, 2022 | Returned to company | −29,000 | $1333.00 | $38.66M | 0 |
| Capital Management LP Rubric 10% owner | Dec 30, 2022 | Sale | −29,000 | $1333.00 | $38.66M | 0 |
| Capital Management LP Rubric 10% owner | Dec 9, 2022 | Buy | +14,825 | $6.09 | $90.28K | 1,757,191 |
| Brian Bernick Co-Chief Executive Officer | Dec 9, 2022 | Sale | −320 | $6.31 | $2.02K | 3,872 |
| Marlan D. Walker Chief Executive Officer | Dec 8, 2022 | Gift | −716 | – | – | 5,969 |
| David Efraim Rosen 10% owner | Dec 8, 2022 | Buy | +300 | $5.83 | $1.75K | 1,742,366 |
| David Efraim Rosen 10% owner | Dec 7, 2022 | Buy | +20,113 | $5.66 | $113.84K | 1,742,066 |
| Gail K. Naughton Director | Dec 7, 2022 | Sale | −3,922 | $5.26 | $20.63K | 0 |
| Marlan D. Walker General Counsel | Dec 6, 2022 | Option exercise | +1,010 | – | – | 6,189 |
| Marlan D. Walker General Counsel | Dec 6, 2022 | Option exercise | +388 | – | – | 7,733 |
| Marlan D. Walker General Counsel | Dec 6, 2022 | Sale | −1,048 | $4.95 | $5.19K | 6,685 |
| Marlan D. Walker General Counsel | Dec 6, 2022 | Option exercise | +1,156 | – | – | 7,345 |
| Michael C. Donegan Interim CFO/CAO/VP of Finance | Dec 6, 2022 | Option exercise | +2,300 | – | – | 4,288 |
| Michael C. Donegan Interim CFO/CAO/VP of Finance | Dec 6, 2022 | Option exercise | +380 | – | – | 4,668 |
| Michael C. Donegan Interim CFO/CAO/VP of Finance | Dec 6, 2022 | Option exercise | +534 | – | – | 5,202 |
| Michael C. Donegan Interim CFO/CAO/VP of Finance | Dec 6, 2022 | Sale | −910 | $4.78 | $4.35K | 4,554 |
| Michael C. Donegan Interim CFO/CAO/VP of Finance | Dec 6, 2022 | Option exercise | +262 | – | – | 5,464 |
| Mark A. Glickman Co-Chief Executive Officer | Dec 6, 2022 | Option exercise | +1,734 | – | – | 1,734 |
| Mark A. Glickman Co-Chief Executive Officer | Dec 6, 2022 | Sale | −440 | $4.92 | $2.16K | 1,294 |
| Brian Bernick Co-Chief Executive Officer | Dec 6, 2022 | Sale | −935 | $4.92 | $4.60K | 4,192 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Marlan D. Walker Officer | Dec 6, 2023 | 28,134 | $70.06K | Dec 6, 2023 | RSU |